Clinical TrialsSearch results
Number of results: 271
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- EvoPAR-Prostate01
- Metastatic Castration-Sensitive Prostate Cancer
- Hibi Kazushige
- 2024-01-12
Recruiting
- Examination of safe apheresis implementation method
- Diseases that require leukocyte apheresis
- Yanagisawa Ryu
- 2021-10-02
Recruiting
- Genetic analyses associated with T or NK cells
- Large granular lymphocytic leukemia, pure red cell aplasia, and so on
- Ishida Fumihiro
- 2022-06-22
Recruiting
- HED-TRC
- Hereditary Dementia
- Yoshiki Sekijima
- 2024-02-14
Recruiting
- Investigator-initiated, first-in-human trial of non-virally engineered GMR CAR T cells against CD116-positive acute myeloid leukemia and juvenile myelomonocytic leukemia.
- CD116-positive acute myeloid leukemia and juvenile myelomonocytic leukemia
- Nakazawa Yozo
- 2021-04-09
Recruiting
- Okaya cohort study
- Early detection and intervention of mental health problems
- Sasayama Daimei Daimei
- 2022-08-19
Recruiting
- Phase I clinical study on the safety of HER2-specific chimeric antigen receptor (CAR) gene-modified T cell therapy
- HER2 positive osteosarcoma/soft tissue sarcoma and gynecologic malignancy
- Yozo Nakazawa
- 2022-05-25
Recruiting
- Phase II Study of Amrubicin and Nitroglycerin in Third-Line Chemotherapy in Previously Treated Patients with Non-Small-Cell Lung Cancer
- Previously treated non-small-cell lung cancer
- Division of Clinical Trial Design and Management, Translational Clinical Center, Kyoto University Hospital
- 2007-09-12
Recruiting
- Phase II trial using imatinib combined with chemotherapy for newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Japan Adult Leukemia Study Group
- 2008-07-07
Recruiting
- Phase two clinical trial of limited stage lymphoblastic lymphoma.
- Limited stage lymphoblastic lymphoma
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26